Patents by Inventor Rasmus Lewinsky

Rasmus Lewinsky has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20090270449
    Abstract: Disclosed herein is a novel class of aminophenyl compounds having the structure: wherein R1 is cyano or nitro and ring A is a bi- or tricyclic bridged heterocycle and to their use as modulators of androgen receptor for the treatment or prevention of conditions relating thereto.
    Type: Application
    Filed: June 30, 2009
    Publication date: October 29, 2009
    Inventors: NATHALIE SCHLIENGER, Mikkel Boas Thygesen, Jan Pawlas, Fabrizio Badalassi, Rasmus Lewinsky, Birgitte Winther Lund, Roger Olsson
  • Patent number: 7585877
    Abstract: Disclosed herein is a novel class of aminophenyl compounds having the structure: wherein R1 is cyano or nitro and ring A is a bi- or tricyclic bridged heterocycle and to their use as modulators of androgen receptor for the treatment or prevention of conditions relating thereto.
    Type: Grant
    Filed: January 9, 2006
    Date of Patent: September 8, 2009
    Inventors: Nathalie Schlienger, Mikkel Boas Thygesen, Jan Pawlas, Fabrizio Badalassi, Rasmus Lewinsky, Birgitte Winther Lund, Roger Olsson
  • Publication number: 20080009489
    Abstract: Disclosed herein are bicycloaryl compounds of Formula (I) that selectively modulate nuclear receptors, preferably the androgen receptor, or a pharmaceutically acceptable salt, ester, amide, or prodrug thereof, and methods of treating disease comprising administering a compound of Formula (I) to a patient in need thereof.
    Type: Application
    Filed: June 28, 2007
    Publication date: January 10, 2008
    Applicant: Acadian Pharmaceuticals, Inc.
    Inventors: Nathalie Schlienger, Jan Pawlas, Alma Fejzic, Roger Olsson, Birgitte Lund, Fabrizio Badalassi, Rasmus Lewinsky, Mikkel Thygesen
  • Patent number: 7268232
    Abstract: Disclosed herein are bicycloaryl compounds of Formula (I) that selectively modulate nuclear receptors, preferably the androgen receptor, or a pharmaceutically acceptable salt, ester, amide, or prodrug thereof, and methods of treating disease comprising administering a compound of Formula (I) to a patient in need thereof.
    Type: Grant
    Filed: May 16, 2005
    Date of Patent: September 11, 2007
    Assignee: Acadia Pharmaceuticals Inc.
    Inventors: Nathalie Schlienger, Jan Pawlas, Alma Fejzic, Roger Olsson, Birgitte Winther Lund, Fabrizio Badalassi, Rasmus Lewinsky, Mikkel Boas Thygesen
  • Publication number: 20070004679
    Abstract: Disclosed herein are bicycloaryl compounds of Formula (I) that selectively modulate nuclear receptors, preferably the androgen receptor, or a pharmaceutically acceptable salt, ester, amide, or prodrug thereof, and methods of treating disease comprising administering a compound of Formula (I) to a patient in need thereof.
    Type: Application
    Filed: February 6, 2006
    Publication date: January 4, 2007
    Inventors: Nathalie Schlienger, Jan Pawlas, Alma Fejzic, Roger Olsson, Birgitte Lund, Fabrizio Badalassi, Rasmus Lewinsky, Mikkel Thygesen, Douglas Bonhaus
  • Publication number: 20060173037
    Abstract: Disclosed herein is a novel class of aminophenyl compounds having the structure: wherein R1 is cyano or nitro and ring A is a bi- or tricyclic bridged heterocycle and to their use as modulators of androgen receptor for the treatment or prevention of conditions relating thereto.
    Type: Application
    Filed: February 6, 2006
    Publication date: August 3, 2006
    Inventors: Nathalie Schlienger, Mikkel Thygesen, Jan Pawlas, Fabrizio Badalassi, Rasmus Lewinsky, Birgitte Lund, Roger Olsson
  • Publication number: 20060160845
    Abstract: Disclosed herein is a novel class of aminophenyl compounds having the structure: wherein R1 is cyano or nitro and ring A is a bi- or tricyclic bridged heterocycle and to their use as modulators of androgen receptor for the treatment or prevention of conditions relating thereto.
    Type: Application
    Filed: January 9, 2006
    Publication date: July 20, 2006
    Inventors: Nathalie Schlienger, Mikkel Thygesen, Jan Pawlas, Fabrizio Badalassi, Rasmus Lewinsky, Birgitte Lund, Roger Olsson
  • Publication number: 20060014739
    Abstract: Disclosed herein are bicycloaryl compounds of Formula (I) that selectively modulate nuclear receptors, preferably the androgen receptor, or a pharmaceutically acceptable salt, ester, amide, or prodrug thereof, and methods of treating disease comprising administering a compound of Formula (I) to a patient in need thereof.
    Type: Application
    Filed: May 16, 2005
    Publication date: January 19, 2006
    Inventors: Nathalie Schlienger, Jan Pawlas, Alma Fejzic, Roger Olsson, Birgitte Lund, Fabrizio Badalassi, Rasmus Lewinsky, Mikkel Thygesen